Full length articleCharacterization of impurities in Sodium cromoglycate (cas 15826-37-6) drug substance and eye drops using LC-ESI-ion trap MS and LC-ESI-QTOF MS
-
Add time:09/25/2019 Source:sciencedirect.com
As requested by regulatory authorities, impurity profiling is an important issue of quality control. In this work, a simple and sensitive liquid chromatographic (LC) method compatible with mass spectrometry (MS) was developed to study related substances and degradation products in Sodium cromoglycate (cas 15826-37-6) drug substance and eye drops. The method used a Sunfire column (4.6 mm × 150 mm, 3.5 μm). Mobile phase A consisted of 10 mM ammonium formate and mobile phase B was acetonitrile. Linear gradient elution with a post-run time of 8 min was performed as follows: 0–30 min, 3% B to 50% B; 30–35 min, 50% B. The flow rate was set at 1.0 mL/min. Degradation experiments were performed to check the stability indicating properties of the developed method. Based on MSn spectral data and exact mass measurements, the chemical structures of 2 unknown impurities and 6 unknown degradation products were characterized, including impurity C listed in the European Pharmacopoeia as unknown structure. In addition, a plausible mechanism for the formation of the degradation products was also proposed.
We also recommend Trading Suppliers and Manufacturers of Sodium cromoglycate (cas 15826-37-6). Pls Click Website Link as below: cas 15826-37-6 suppliers
Prev:Sodium cromoglycate (cas 15826-37-6) reduces short- and long-term consequences of status epilepticus in rats
Next:Preliminary reportNasal Sodium cromoglycate (cas 15826-37-6) (Lomusol) modulates the early phase reaction of mild to moderate persistent allergic rhinitis in patients mono-sensitized to house dust mite: A preliminary study) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Determination of Sodium cromoglycate (cas 15826-37-6) in human plasma by liquid chromatography–mass spectrometry in the turbo ion spray mode09/30/2019
- Effects of nebulized Sodium cromoglycate (cas 15826-37-6) on adult patients with severe refractory asthma09/29/2019
- Short communicationDevelopment and validation of an ion-pair liquid chromatographic method for the quantitation of Sodium cromoglycate (cas 15826-37-6) in urine following inhalation09/28/2019
- Equilibrium and kinetic aspects of Sodium cromoglycate (cas 15826-37-6) adsorption on chitosan: Mass uptake and surface charging considerations10/01/2019
- The mast cell stabilizer Sodium cromoglycate (cas 15826-37-6) reduces histamine release and status epilepticus-induced neuronal damage in the rat hippocampus09/27/2019
- Preliminary reportNasal Sodium cromoglycate (cas 15826-37-6) (Lomusol) modulates the early phase reaction of mild to moderate persistent allergic rhinitis in patients mono-sensitized to house dust mite: A preliminary study09/26/2019
- Sodium cromoglycate (cas 15826-37-6) reduces short- and long-term consequences of status epilepticus in rats09/24/2019
-
Health and Chemical more >
-
Related Products
- Sodium 2,4-dimethylbenzenesulfonate
- SODIUM γ-FLUORO-β-HYDROXYBUTYRATE
- Sodium ((3-methoxy-1-methyl-3-oxo-1-propenyl)amino)phenylacetate
- Sodium (+)-10-camphorsulfonate
- Sodium (2-carbamoylphenoxy)acetate
- Sodium (2-methyl-4-chlorophenoxy)acetate
- Sodium (6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate pentahydrate
- Sodium (C10-16)alkylbenzenesulfonate
- Sodium (R,R)-5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)amino)propyl)-1,3-benzodioxole-2,2-
- Sodium (S)-lactate